Literature DB >> 8423786

Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase.

E M Lees1, E Harlow.   

Abstract

Cyclins are pivotal in the coordinate regulation of the cell cycle. By physical association, they are able to activate at least one of the cyclin-dependent kinases, cdc2. How this association between the catalytic moiety and cyclins leads to subsequent activation of the kinase remains unclear. In this report, we describe experiments to investigate this event at a physical level. Our approach was to map the regions required on the cyclin A molecule for interaction with cdc2. We have mapped the contact regions to two small noncontiguous stretches of amino acids, residues 189 to 241 and 275 to 320, both located within the conserved cyclin box domain of the protein. We have further shown that this region not only represents a contact site for cdc2 but apparently represents an intact functional domain with respect to cdc2 activation. This region alone is sufficient to stimulate maturation when injected into immature Xenopus laevis oocytes. This observation implies that events leading to the activation of cdc2 kinase can be mediated through small regions of the cyclin molecule that are located in the cyclin box. These regions contain some of the most highly conserved residues found between all the cyclin members so far identified. This suggests that the cyclin family members may have conserved a similar mechanism to bind and activate cyclin-dependent kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423786      PMCID: PMC359004          DOI: 10.1128/mcb.13.2.1194-1201.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components.

Authors:  P Pondaven; L Meijer; D Beach
Journal:  Genes Dev       Date:  1990-01       Impact factor: 11.361

2.  An essential G1 function for cyclin-like proteins in yeast.

Authors:  H E Richardson; C Wittenberg; F Cross; S I Reed
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Mitotic role for the Cdc28 protein kinase of Saccharomyces cerevisiae.

Authors:  S I Reed; C Wittenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  G1-specific cyclins of S. cerevisiae: cell cycle periodicity, regulation by mating pheromone, and association with the p34CDC28 protein kinase.

Authors:  C Wittenberg; K Sugimoto; S I Reed
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

5.  Cyclin activation of p34cdc2.

Authors:  M J Solomon; M Glotzer; T H Lee; M Philippe; M W Kirschner
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

6.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

Authors:  J Pines; T Hunter
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

7.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

8.  Cyclin is a component of maturation-promoting factor from Xenopus.

Authors:  J Gautier; J Minshull; M Lohka; M Glotzer; T Hunt; J L Maller
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

9.  The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations.

Authors:  Q J Hu; N Dyson; E Harlow
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.

Authors:  W Krek; E A Nigg
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  38 in total

Review 1.  Demystified ... cell cycle.

Authors:  C E Gillett; D M Barnes
Journal:  Mol Pathol       Date:  1998-12

2.  The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway.

Authors:  G Hautbergue; V Goguel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 3.  Factors controlling cyclin B expression.

Authors:  M Ito
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

4.  A nonproteolytic function of the proteasome is required for the dissociation of Cdc2 and cyclin B at the end of M phase.

Authors:  A Nishiyama; K Tachibana; Y Igarashi; H Yasuda; N Tanahashi; K Tanaka; K Ohsumi; T Kishimoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

5.  Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.

Authors:  Xin-Hua Zhu; Hoang Nguyen; H Dorota Halicka; Frank Traganos; Andrew Koff
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

7.  Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.

Authors:  Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

8.  Function of a human cyclin gene as an oncogene.

Authors:  P W Hinds; S F Dowdy; E N Eaton; A Arnold; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.

Authors:  Maike Zimmermann; Aruni P S Arachchige-Don; Michaela S Donaldson; Tommaso Patriarchi; Mary C Horne
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.